{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:04:13Z","timestamp":1793163853293,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82401070"],"award-info":[{"award-number":["82401070"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["W2523106"],"award-info":[{"award-number":["W2523106"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82372735"],"award-info":[{"award-number":["82372735"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75830-y","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:14:35Z","timestamp":1784762075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RHOT1\/2-driven mitochondrial membrane vesicles confer tumor-homing selectivity and enable in situ cancer vaccination"],"prefix":"10.1038","volume":"17","author":[{"given":"Wanrong","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-9098","authenticated-orcid":false,"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiquan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1446-0692","authenticated-orcid":false,"given":"Longjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"75830_CR1","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41551-019-0436-x","volume":"3","author":"L Scheetz","year":"2019","unstructured":"Scheetz, L. et al. Engineering patient-specific cancer immunotherapies. Nat. Biomed. Eng. 3, 768\u2013782 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"75830_CR2","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","volume":"20","author":"K Yang","year":"2023","unstructured":"Yang, K., Halima, A. & Chan, T. A. Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy. Nat. Rev. Clin. Oncol. 20, 604\u2013623 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"75830_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s43018-023-00588-x","volume":"4","author":"A Peri","year":"2023","unstructured":"Peri, A. et al. The landscape of T cell antigens for cancer immunotherapy. Nat. Cancer 4, 937\u2013954 (2023).","journal-title":"Nat. Cancer"},{"key":"75830_CR4","first-page":"86","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy, L. B. & Salama, A. K. S. A review of cancer immunotherapy toxicity. CA Cancer J. Clin. 70, 86\u2013104 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"75830_CR5","doi-asserted-by":"crossref","unstructured":"Gong, J. et al. Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy. Adv. Sci. 13, e15403 (2026).","DOI":"10.1002\/advs.202515403"},{"key":"75830_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","volume":"21","author":"M Saxena","year":"2021","unstructured":"Saxena, M., van der Burg, S. H., Melief, C. J. M. & Bhardwaj, N. Therapeutic cancer vaccines. Nat. Rev. Cancer 21, 360\u2013378 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"75830_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","volume":"359","author":"U Sahin","year":"2018","unstructured":"Sahin, U. & T\u00fcreci, \u00d6 Personalized vaccines for cancer immunotherapy. Science 359, 1355\u20131360 (2018).","journal-title":"Science"},{"key":"75830_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300121","volume":"10","author":"L Diao","year":"2023","unstructured":"Diao, L. & Liu, M. Rethinking antigen source: cancer vaccines based on whole tumor cell\/tissue lysate or whole tumor cell. Adv. Sci. 10, e2300121 (2023).","journal-title":"Adv. Sci."},{"key":"75830_CR9","doi-asserted-by":"publisher","unstructured":"A whole cancer cell-based vaccine boosts cell killing and antitumor immunity. Cancer Discov. 13, Of5 https:\/\/doi.org\/10.1158\/2159-8290.Cd-rw2023-008 (2023).","DOI":"10.1158\/2159-8290.Cd-rw2023-008"},{"key":"75830_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1586\/14760584.2014.911093","volume":"13","author":"L Cicchelero","year":"2014","unstructured":"Cicchelero, L., de Rooster, H. & Sanders, N. N. Various ways to improve whole cancer cell vaccines. Expert Rev. Vaccines 13, 721\u2013735 (2014).","journal-title":"Expert Rev. Vaccines"},{"key":"75830_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121297","volume":"280","author":"DI Viswanath","year":"2022","unstructured":"Viswanath, D. I., Liu, H. C., Huston, D. P., Chua, C. Y. X. & Grattoni, A. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 280, 121297 (2022).","journal-title":"Biomaterials"},{"key":"75830_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","volume":"23","author":"N Gong","year":"2024","unstructured":"Gong, N. et al. Enhancing in situ cancer vaccines using delivery technologies. Nat. Rev. Drug Discov. 23, 607\u2013625 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75830_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-024-06644-3","volume":"15","author":"W Guo","year":"2024","unstructured":"Guo, W. et al. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram\/copper-mediated enhanced immunogenic cell death of breast cancer cells. Cell Death Dis. 15, 298 (2024).","journal-title":"Cell Death Dis."},{"key":"75830_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"75830_CR15","doi-asserted-by":"publisher","unstructured":"Wu, J. et al. An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug\/gene delivery nanoparticles. Sci. Adv. 6, https:\/\/doi.org\/10.1126\/sciadv.abc7828 (2020).","DOI":"10.1126\/sciadv.abc7828"},{"key":"75830_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210452","volume":"36","author":"Y Bo","year":"2024","unstructured":"Bo, Y. & Wang, H. Biomaterial-based in situ cancer vaccines. Adv. Mater. 36, e2210452 (2024).","journal-title":"Adv. Mater."},{"key":"75830_CR17","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56, 2188\u20132205 (2023).","journal-title":"Immunity"},{"key":"75830_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221096219","volume":"14","author":"AM Starzer","year":"2022","unstructured":"Starzer, A. M., Preusser, M. & Berghoff, A. S. Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle. Ther. Adv. Med. Oncol. 14, 17588359221096219 (2022).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"75830_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.apsb.2021.05.031","volume":"12","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle. Acta Pharm. Sin. B 12, 107\u2013134 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"75830_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2019.114427","volume":"459","author":"GM Lynn","year":"2019","unstructured":"Lynn, G. M., Laga, R. & Jewell, C. M. Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines. Cancer Lett. 459, 192\u2013203 (2019).","journal-title":"Cancer Lett."},{"key":"75830_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade6257","volume":"9","author":"F Cheng","year":"2023","unstructured":"Cheng, F. et al. Single-dose injectable nanovaccine-in-hydrogel for robust immunotherapy of large tumors with abscopal effect. Sci. Adv. 9, eade6257 (2023).","journal-title":"Sci. Adv."},{"key":"75830_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40207-y","volume":"14","author":"J Meng","year":"2023","unstructured":"Meng, J. et al. Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. Nat. Commun. 14, 4505 (2023).","journal-title":"Nat. Commun."},{"key":"75830_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202211485","volume":"35","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. A tumor-microenvironment-activatable molecular pro-theranostic agent for photodynamic and immunotherapy of cancer. Adv. Mater. 35, e2211485 (2023).","journal-title":"Adv. Mater."},{"key":"75830_CR24","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/acsnano.3c10225","volume":"18","author":"P Xu","year":"2024","unstructured":"Xu, P. et al. Radiotherapy-triggered in situ tumor vaccination boosts checkpoint blockaded immune response via antigen-capturing nanoadjuvants. ACS Nano 18, 1022\u20131040 (2024).","journal-title":"ACS Nano"},{"key":"75830_CR25","doi-asserted-by":"publisher","unstructured":"Ye, J. et al. Toll-like receptor 7\/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. J. Immunother. Cancer 10, https:\/\/doi.org\/10.1136\/jitc-2022-004784 (2022).","DOI":"10.1136\/jitc-2022-004784"},{"key":"75830_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202307193","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Laser-activatable in situ vaccine enhances cancer-immunity cycle. Adv. Mater. 35, e2307193 (2023).","journal-title":"Adv. Mater."},{"key":"75830_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403158","volume":"11","author":"X An","year":"2024","unstructured":"An, X. et al. Light-activated in situ vaccine with enhanced cytotoxic T lymphocyte infiltration and function for potent cancer immunotherapy. Adv. Sci. 11, e2403158 (2024).","journal-title":"Adv. Sci."},{"key":"75830_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley, R. S., June, C. H., Langer, R. & Mitchell, M. J. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18, 175\u2013196 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"75830_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114652","volume":"43","author":"X Qiao","year":"2024","unstructured":"Qiao, X. et al. Beyond mitochondrial transfer, cell fusion rescues metabolic dysfunction and boosts malignancy in adenoid cystic carcinoma. Cell Rep. 43, 114652 (2024).","journal-title":"Cell Rep."},{"key":"75830_CR30","doi-asserted-by":"crossref","unstructured":"Li, B. et al. Targeting mitochondrial transfer as a promising therapeutic strategy. Trends Mol. Med. 31, 909\u2013924 (2025).","DOI":"10.1016\/j.molmed.2025.04.002"},{"key":"75830_CR31","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cmet.2024.05.016","volume":"36","author":"J Zhou","year":"2024","unstructured":"Zhou, J. et al. Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation. Cell Metab. 36, 2054\u20132068.e2014 (2024).","journal-title":"Cell Metab."},{"key":"75830_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.neuron.2021.11.020","volume":"110","author":"M van der Vlist","year":"2022","unstructured":"van der Vlist, M. et al. Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain. Neuron 110, 613\u2013626.e619 (2022).","journal-title":"Neuron"},{"key":"75830_CR33","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.ccell.2023.09.003","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution. Cancer Cell 41, 1788\u20131802.e1710 (2023).","journal-title":"Cancer Cell"},{"key":"75830_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41565-021-01000-4","volume":"17","author":"T Saha","year":"2022","unstructured":"Saha, T. et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat. Nanotechnol. 17, 98\u2013106 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"75830_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13046-024-03069-w","volume":"43","author":"F Guan","year":"2024","unstructured":"Guan, F. et al. Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy. J. Exp. Clin. Cancer Res. 43, 147 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"75830_CR36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s10495-023-01847-z","volume":"28","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. TFAM-mediated mitochondrial transfer of MSCs improved the permeability barrier in sepsis-associated acute lung injury. Apoptosis 28, 1048\u20131059 (2023).","journal-title":"Apoptosis"},{"key":"75830_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s43018-023-00556-5","volume":"4","author":"DC Watson","year":"2023","unstructured":"Watson, D. C. et al. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nat. Cancer 4, 648\u2013664 (2023).","journal-title":"Nat. Cancer"},{"key":"75830_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw7215","volume":"5","author":"J Gao","year":"2019","unstructured":"Gao, J. et al. Endoplasmic reticulum mediates mitochondrial transfer within the osteocyte dendritic network. Sci. Adv. 5, eaaw7215 (2019).","journal-title":"Sci. Adv."},{"key":"75830_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-024-03087-8","volume":"43","author":"V Del Vecchio","year":"2024","unstructured":"Del Vecchio, V. et al. Mitochondrial transfer from adipose stem cells to breast cancer cells drives multi-drug resistance. J. Exp. Clin. Cancer Res. 43, 166 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"75830_CR40","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/s41388-019-0805-7","volume":"38","author":"L Ippolito","year":"2019","unstructured":"Ippolito, L. et al. Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer. Oncogene 38, 5339\u20135355 (2019).","journal-title":"Oncogene"},{"key":"75830_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41594-022-00749-z","volume":"29","author":"EA Partlow","year":"2022","unstructured":"Partlow, E. A., Cannon, K. S., Hollopeter, G. & Baker, R. W. Structural basis of an endocytic checkpoint that primes the AP2 clathrin adaptor for cargo internalization. Nat. Struct. Mol. Biol. 29, 339\u2013347 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75830_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrm.2017.132","volume":"19","author":"M Kaksonen","year":"2018","unstructured":"Kaksonen, M. & Roux, A. Mechanisms of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 19, 313\u2013326 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75830_CR43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding, N. & Brestoff, J. R. The power and potential of mitochondria transfer. Nature 623, 283\u2013291 (2023).","journal-title":"Nature"},{"key":"75830_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41518-w","volume":"14","author":"S Mayer","year":"2023","unstructured":"Mayer, S. et al. The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts. Nat. Commun. 14, 5810 (2023).","journal-title":"Nat. Commun."},{"key":"75830_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li, X., Lovell, J. F., Yoon, J. & Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 17, 657\u2013674 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"75830_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2020.06.032","volume":"325","author":"D Zhi","year":"2020","unstructured":"Zhi, D., Yang, T., O\u2019Hagan, J., Zhang, S. & Donnelly, R. F. Photothermal therapy. J. Control. Release. 325, 52\u201371 (2020).","journal-title":"J. Control. Release."},{"key":"75830_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01798-8","volume":"22","author":"P Kesharwani","year":"2023","unstructured":"Kesharwani, P. et al. Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Mol. Cancer 22, 98 (2023).","journal-title":"Mol. Cancer"},{"key":"75830_CR48","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester, S. N. & Li, K. Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426, 1246\u20131264 (2014).","journal-title":"J. Mol. Biol."},{"key":"75830_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature09973","volume":"472","author":"AP West","year":"2011","unstructured":"West, A. P. et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476\u2013480 (2011).","journal-title":"Nature"},{"key":"75830_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nri3652","volume":"14","author":"E Kugelberg","year":"2014","unstructured":"Kugelberg, E. Dendritic cells: TLR agonists trigger rapid metabolic changes. Nat. Rev. Immunol. 14, 209 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"75830_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cmi.2012.61","volume":"10","author":"Z Hua","year":"2013","unstructured":"Hua, Z. & Hou, B. TLR signaling in B-cell development and activation. Cell. Mol. Immunol. 10, 103\u2013106 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"75830_CR52","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","volume":"56","author":"LL Cao","year":"2023","unstructured":"Cao, L. L. & Kagan, J. C. Targeting innate immune pathways for cancer immunotherapy. Immunity 56, 2206\u20132217 (2023).","journal-title":"Immunity"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75830-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75830-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75830-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:20:17Z","timestamp":1787613617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75830-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75830"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75830-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8959"}}